DIZAL (JIANGSU) PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 688192 for the last quarter is 81.08 M CNY, and it's 59.28% higher compared to the previous quarter. The net income of Q1 24 is -224.23 M CNY.